According to our (Global Info Research) latest study, the global Gene-Edited Donor Animal Breeding System market size was valued at US$ 130 million in 2025 and is forecast to a readjusted size of US$ 629 million by 2032 with a CAGR of 25.3% during review period.
Gene-edited donor animal breeding system is an integrated breeding and quality-control platform for xenotransplantation donor animals, mainly pigs. It covers multiplex CRISPR/Cas editing, somatic cell nuclear transfer or embryo editing, SPF/DPF barrier breeding, pathogen elimination and monitoring, pedigree tracking, tissue matching, and pre-procurement release testing for donor animals supplying kidneys, hearts, livers, lungs, islets, cells, tissues, and organs. The system usually emphasizes edit stability, PERV inactivation, immune compatibility, human transgene expression, designated-pathogen control, reproductive performance, and regulatory traceability, with gross margin of about 55%.
As xenotransplantation moves from preclinical work into early clinical validation, donor animal breeding is no longer only a laboratory animal production step; it has become an upstream platform that determines organ safety, immune compatibility, and batch traceability. Demand for reliable donor sources is increasing in kidney, heart, liver, lung, and islet programs, while hospitals, translational centers, and biotechnology companies place more value on releasable, traceable, and repeatable donor animal systems.
Product upgrading is centered on multiplex gene-editing packages, PERV inactivation, designated-pathogen-free barrier breeding, and organ-specific donor lineages. Leading companies tend to integrate genome editing, cloning, animal facilities, pathogen testing, and organ procurement into closed platform capabilities, while smaller participants usually enter the market through donor-line licensing, contract breeding, and joint development for selected organs or regions.
The United States leads in clinical trials and industrialized production, while China and Japan are accelerating donor pig herd construction, DPF facilities, and clinical translation; Europe is more focused on heart programs and preclinical validation. Opportunities come from organ shortages, clearer regulatory pathways, and multi-center clinical collaboration, while risks remain in long-term immune rejection, cross-species pathogen control, animal ethics, facility investment, and differences in clinical release standards.
Report Scope
This report is a detailed and comprehensive analysis for global Gene-Edited Donor Animal Breeding System market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Gene-Edited Donor Animal Breeding System market size and forecasts, in consumption value ($ Million), 2021-2032
Global Gene-Edited Donor Animal Breeding System market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Gene-Edited Donor Animal Breeding System market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Gene-Edited Donor Animal Breeding System market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gene-Edited Donor Animal Breeding System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gene-Edited Donor Animal Breeding System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include eGenesis, United Therapeutics / Revivicor, Qihan Biotech, ClonOrgan, PorMedTec, Makana Therapeutics, XenoTherapeutics, XTransplant, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Gene-Edited Donor Animal Breeding System market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Kidney Donor Animal Breeding System
Heart Donor Animal Breeding System
Liver Donor Animal Breeding System
Lung Donor Animal Breeding System
Islet and Cell Donor Animal Breeding System
Tissue Donor Animal Breeding System
Market segment by Gene Edit Package
Single-Gene Knockout Breeding System
Triple-Knockout Breeding System
Knockout and Human Transgene Breeding System
PERV-Inactivated Multi-Edit Breeding System
Custom Gene Edit Breeding System
Market segment by Pathogen Control Grade
Conventional Clean Breeding System
SPF Breeding System
DPF Breeding System
Gnotobiotic Breeding System
Clinical-Release Breeding System
Market segment by Delivery Mode
Turnkey Barrier Facility System
Modular Breeding Suite System
Contract Breeding Service System
Donor Line Licensing System
Joint Development Breeding Platform
Market segment by Application
Xenogeneic Kidney Transplantation
Xenogeneic Heart Transplantation
Xenogeneic Liver Support and Transplantation
Xenogeneic Lung Transplantation
Islet and Cell Therapy
Preclinical Safety and Compatibility Research
Market segment by players, this report covers
eGenesis
United Therapeutics / Revivicor
Qihan Biotech
ClonOrgan
PorMedTec
Makana Therapeutics
XenoTherapeutics
XTransplant
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Gene-Edited Donor Animal Breeding System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene-Edited Donor Animal Breeding System, with revenue, gross margin, and global market share of Gene-Edited Donor Animal Breeding System from 2021 to 2026.
Chapter 3, the Gene-Edited Donor Animal Breeding System competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Gene-Edited Donor Animal Breeding System market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene-Edited Donor Animal Breeding System.
Chapter 13, to describe Gene-Edited Donor Animal Breeding System research findings and conclusion.
Summary:
Get latest Market Research Reports on Gene-Edited Donor Animal Breeding System. Industry analysis & Market Report on Gene-Edited Donor Animal Breeding System is a syndicated market report, published as Global Gene-Edited Donor Animal Breeding System Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Gene-Edited Donor Animal Breeding System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.